Probiotic Infant Use Raises FDA, Food Advisory Committee Concern

FDA expressed concerns regarding a 75-day premarket notification for a probiotic containing Lactobacillus reuteri due to inadequate information on the bacteria's safety in infants and young children. The notification was submitted June 30 by McNeil Consumer Healthcare.